Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study

Shai Levi; Yotam Bronstein; Neta Goldschmidt; Fortunato Morabito; Tomer Ziv-Baran; Giovanni Del Poeta; Osnat Bairey; Maria Ilaria Del Principe; Riva Fineman; Francesca Romana Mauro; Odit Gutwein; Gianluigi Reda; Rosa Ruchlemer; Paolo Sportoletti; Luca Laurenti; Lev Shvidel; Marta Coscia; Tamar Tadmor; Marzia Varettoni; Ariel Aviv; Roberta Murru; Andrei Braester; Annalisa Chiarenza; Andrea Visentin; Daniela Pietrasanta; Giacomo Loseto; Antonella Zucchetto; Riccardo Bomben; Jacopo Olivieri; Antonio Neri; Davide Rossi; Gianluca Gaidano; Livio Trentin; Robin Foà; Antonio Cuneo; Chava Perry; Valter Gattei; Massimo Gentile; Yair Herishanu

doi:10.1002/ajh.26779

Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study

Shai Levi, Yotam Bronstein, Neta Goldschmidt, Fortunato Morabito, Tomer Ziv-Baran, Giovanni Del Poeta, Osnat Bairey, Maria Ilaria Del Principe, Riva Fineman, Francesca Romana Mauro, Odit Gutwein, Gianluigi Reda, Rosa Ruchlemer, Paolo Sportoletti, Luca Laurenti, Lev Shvidel, Marta Coscia, Tamar Tadmor, Marzia Varettoni, Ariel AvivRoberta Murru, Andrei Braester, Annalisa Chiarenza, Andrea Visentin, Daniela Pietrasanta, Giacomo Loseto, Antonella Zucchetto, Riccardo Bomben, Jacopo Olivieri, Antonio Neri, Davide Rossi, Gianluca Gaidano, Livio Trentin, Robin Foà, Antonio Cuneo, Chava Perry, Valter Gattei, Massimo Gentile, Yair Herishanu

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Lettera › peer review

Lingua originale	Inglese
pagine (da-a)	E24-E27
Rivista	American Journal of Hematology
Volume	98
Numero di pubblicazione	2
DOI	https://doi.org/10.1002/ajh.26779
Stato di pubblicazione	Pubblicato - feb 2023

Accesso al documento

10.1002/ajh.26779

Altri file e collegamenti

Link to publication in Scopus

Cita questo

Levi, S., Bronstein, Y., Goldschmidt, N., Morabito, F., Ziv-Baran, T., Del Poeta, G., Bairey, O., Del Principe, M. I., Fineman, R., Mauro, F. R., Gutwein, O., Reda, G., Ruchlemer, R., Sportoletti, P., Laurenti, L., Shvidel, L., Coscia, M., Tadmor, T., Varettoni, M., ... Herishanu, Y. (2023). Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study. American Journal of Hematology, 98(2), E24-E27. https://doi.org/10.1002/ajh.26779

@article{a7d7086b0d064e7290cfbeddeffd93f2,

title = "Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study",

author = "Shai Levi and Yotam Bronstein and Neta Goldschmidt and Fortunato Morabito and Tomer Ziv-Baran and \{Del Poeta\}, Giovanni and Osnat Bairey and \{Del Principe\}, \{Maria Ilaria\} and Riva Fineman and Mauro, \{Francesca Romana\} and Odit Gutwein and Gianluigi Reda and Rosa Ruchlemer and Paolo Sportoletti and Luca Laurenti and Lev Shvidel and Marta Coscia and Tamar Tadmor and Marzia Varettoni and Ariel Aviv and Roberta Murru and Andrei Braester and Annalisa Chiarenza and Andrea Visentin and Daniela Pietrasanta and Giacomo Loseto and Antonella Zucchetto and Riccardo Bomben and Jacopo Olivieri and Antonio Neri and Davide Rossi and Gianluca Gaidano and Livio Trentin and Robin Fo{\`a} and Antonio Cuneo and Chava Perry and Valter Gattei and Massimo Gentile and Yair Herishanu",

year = "2023",

month = feb,

doi = "10.1002/ajh.26779",

language = "English",

volume = "98",

pages = "E24--E27",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

Levi, S, Bronstein, Y, Goldschmidt, N, Morabito, F, Ziv-Baran, T, Del Poeta, G, Bairey, O, Del Principe, MI, Fineman, R, Mauro, FR, Gutwein, O, Reda, G, Ruchlemer, R, Sportoletti, P, Laurenti, L, Shvidel, L, Coscia, M, Tadmor, T, Varettoni, M, Aviv, A, Murru, R, Braester, A, Chiarenza, A, Visentin, A, Pietrasanta, D, Loseto, G, Zucchetto, A, Bomben, R, Olivieri, J, Neri, A, Rossi, D, Gaidano, G, Trentin, L, Foà, R, Cuneo, A, Perry, C, Gattei, V, Gentile, M & Herishanu, Y 2023, 'Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study', American Journal of Hematology, vol. 98, n. 2, pagg. E24-E27. https://doi.org/10.1002/ajh.26779

Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study. / Levi, Shai; Bronstein, Yotam; Goldschmidt, Neta et al.
In: American Journal of Hematology, Vol. 98, N. 2, 02.2023, pag. E24-E27.

Risultato della ricerca: Contributo su rivista › Lettera › peer review

TY - JOUR

T1 - Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia

T2 - A retrospective multicenter “Real-World” study

AU - Levi, Shai

AU - Bronstein, Yotam

AU - Goldschmidt, Neta

AU - Morabito, Fortunato

AU - Ziv-Baran, Tomer

AU - Del Poeta, Giovanni

AU - Bairey, Osnat

AU - Del Principe, Maria Ilaria

AU - Fineman, Riva

AU - Mauro, Francesca Romana

AU - Gutwein, Odit

AU - Reda, Gianluigi

AU - Ruchlemer, Rosa

AU - Sportoletti, Paolo

AU - Laurenti, Luca

AU - Shvidel, Lev

AU - Coscia, Marta

AU - Tadmor, Tamar

AU - Varettoni, Marzia

AU - Aviv, Ariel

AU - Murru, Roberta

AU - Braester, Andrei

AU - Chiarenza, Annalisa

AU - Visentin, Andrea

AU - Pietrasanta, Daniela

AU - Loseto, Giacomo

AU - Zucchetto, Antonella

AU - Bomben, Riccardo

AU - Olivieri, Jacopo

AU - Neri, Antonio

AU - Rossi, Davide

AU - Gaidano, Gianluca

AU - Trentin, Livio

AU - Foà, Robin

AU - Cuneo, Antonio

AU - Perry, Chava

AU - Gattei, Valter

AU - Gentile, Massimo

AU - Herishanu, Yair

PY - 2023/2

Y1 - 2023/2

UR - https://www.scopus.com/pages/publications/85145944390

U2 - 10.1002/ajh.26779

DO - 10.1002/ajh.26779

M3 - Letter

SN - 0361-8609

VL - 98

SP - E24-E27

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 2

ER -